Texas Permanent School Fund increased its position in Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) by 9.8% during the third quarter, Holdings Channel reports. The firm owned 27,169 shares of the company’s stock after buying an additional 2,431 shares during the period. Texas Permanent School Fund owned approximately 0.07% of Zeltiq Aesthetics worth $1,066,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. PineBridge Investments L.P. increased its stake in shares of Zeltiq Aesthetics by 4.9% in the second quarter. PineBridge Investments L.P. now owns 4,103 shares of the company’s stock worth $112,000 after buying an additional 193 shares during the last quarter. Teacher Retirement System of Texas increased its stake in shares of Zeltiq Aesthetics by 26.9% in the second quarter. Teacher Retirement System of Texas now owns 4,884 shares of the company’s stock worth $133,000 after buying an additional 1,036 shares during the last quarter. Mason Street Advisors LLC acquired a new stake in shares of Zeltiq Aesthetics during the second quarter worth $173,000. Bank of Montreal Can increased its stake in shares of Zeltiq Aesthetics by 49.2% in the third quarter. Bank of Montreal Can now owns 4,794 shares of the company’s stock worth $188,000 after buying an additional 1,580 shares during the last quarter. Finally, Calamos Wealth Management LLC acquired a new stake in shares of Zeltiq Aesthetics during the second quarter worth $200,000.
Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) traded up 1.77% on Friday, reaching $42.53. The company’s stock had a trading volume of 421,467 shares. The company’s 50 day moving average price is $38.13 and its 200-day moving average price is $34.17. Zeltiq Aesthetics Inc. has a 12-month low of $18.41 and a 12-month high of $43.00. The stock has a market cap of $1.70 billion, a PE ratio of 54.88 and a beta of 0.89.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last released its quarterly earnings results on Wednesday, November 9th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.04. The business earned $95.20 million during the quarter, compared to analyst estimates of $90.84 million. Zeltiq Aesthetics had a negative return on equity of 6.45% and a net margin of 9.48%. Zeltiq Aesthetics’s quarterly revenue was up 55.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.05 EPS. On average, equities analysts expect that Zeltiq Aesthetics Inc. will post ($0.08) EPS for the current year.
A number of brokerages have weighed in on ZLTQ. Canaccord Genuity lifted their target price on Zeltiq Aesthetics from $41.00 to $45.00 and gave the stock a “buy” rating in a report on Thursday, November 10th. Maxim Group raised their price objective on Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research note on Tuesday, August 9th. Zacks Investment Research cut Zeltiq Aesthetics from a “strong-buy” rating to a “hold” rating in a research note on Saturday, November 12th. Leerink Swann reissued an “outperform” rating and issued a $48.00 price objective (up previously from $43.00) on shares of Zeltiq Aesthetics in a research note on Thursday, August 11th. Finally, Brean Capital set a $39.00 price objective on Zeltiq Aesthetics and gave the company a “buy” rating in a research note on Tuesday, August 9th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $42.78.
In other Zeltiq Aesthetics news, insider Mark J. Foley sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, November 14th. The stock was sold at an average price of $39.54, for a total transaction of $395,400.00. Following the completion of the transaction, the insider now owns 261,941 shares of the company’s stock, valued at approximately $10,357,147.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kevin C. Oboyle sold 7,500 shares of the stock in a transaction that occurred on Thursday, September 15th. The stock was sold at an average price of $40.08, for a total value of $300,600.00. Following the completion of the transaction, the director now directly owns 19,485 shares of the company’s stock, valued at approximately $780,958.80. The disclosure for this sale can be found here. Company insiders own 15.60% of the company’s stock.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.